Prostate Cancer - Results from #25660

Diagnostic value of ADC in patients with prostate cancer: Influence of the choice of b values - Abstract June 14, 2012

Dural metastases from prostate cancer mimicking acute sub-dural hematoma - Abstract June 14, 2012

Rye bread consumption in early life and reduced risk of advanced prostate cancer - Abstract June 14, 2012

Dietary intake of B vitamins and methionine and prostate cancer incidence and mortality - Abstract June 14, 2012

Organ-limited prostate cancer with positive resection margins : Importance of adjuvant radiation therapy - Abstract June 14, 2012

Fostering partnerships in survivorship care: Report of the 2011 Canadian genitourinary cancers survivorship conference - Abstract June 14, 2012

Therapeutic strategies for bone metastases and their clinical sequelae in prostate cancer - Abstract June 14, 2012

The influence of distress on knowledge transfer for men newly diagnosed with prostate cancer - Abstract June 14, 2012

A survival score for patients with metastatic spinal cord compression from prostate cancer - Abstract June 13, 2012

Intermittent androgen deprivation as therapy for androgen-sensitive prostate cancer : Sense or nonsense? - Abstract June 13, 2012

Prostate-specific antigen use among men without prostate cancer in France (2008-2010) - Abstract June 13, 2012

Does pelvic lymph node dissection improve the biochemical relapse-free survival in low-risk prostate cancer patients treated by laparoscopic radical prostatectomy? - Abstract June 13, 2012

Experimental investigation of the cytotoxicity of medium-borne signals in human prostate cancer cell line - Abstract June 13, 2012

High-grade prostate cancer: Favorable results in the modern era regardless of initial treatment - Abstract June 13, 2012

Findings in 12-core transrectal ultrasound-guided prostate needle biopsy that predict more advanced cancer at prostatectomy: Analysis of 388 biopsy-prostatectomy pairs - Abstract June 13, 2012

Prognostic role of serum parathyroid hormone levels in advanced prostate cancer patients undergoing zoledronic acid administration - Abstract June 13, 2012

Castration-resistant prostate cancer: Systemic therapy in 2012 - Abstract June 13, 2012

Strategy in advanced castration-resistant prostate cancer - Abstract June 13, 2012

[(18) F]fluoromethylcholine (FCH) positron emission tomography/computed tomography (PET/CT) for lymph node staging of prostate cancer: A prospective study of 210 patients - Abstract June 13, 2012

Ability of C-reactive protein to complement multiple prognostic classifiers in men with metastatic castration resistant prostate cancer receiving docetaxel-based chemotherapy - Abstract June 13, 2012

Page 1284 of 1438